SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (646)1/8/2001 1:52:22 PM
From: tuck  Respond to of 712
 
Folks,

Several other things are going on with CORR this morning.

1) Maintains guidance (actually increased rev estimate slightly)

siliconinvestor.com

2) Co-promotion agreement

siliconinvestor.com

3) Conference call this afternoon.

Cheers, Tuck



To: Icebrg who wrote (646)1/8/2001 7:05:37 PM
From: SemiBull  Read Replies (1) | Respond to of 712
 
Thanks Icebrg....here are two relevant links today from CORR

COR Therapeutics, Inc. Confirms Prior Guidance for Profitable Fourth Quarter of 2000 and Sales of INTEGRILIN in 2000 - COR Updates 2001 INTEGRILIN(R) Sales Estimates
biz.yahoo.com

Integrilin -- eptifibatide -- Injection Significantly Improves Long-term Outcomes in Patients Undergoing Intracoronary Stenting
biz.yahoo.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News